K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

M. Brink*, A.F.P.M. de Goeij, M.P. Weijenberg, G.M.J.M. Roemen, M.H. Lentjens, M.M.M. Pachen, K.M. Smits, A.P. de Bruine, R.A. Goldbohm, P.A. van den Brandt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

308 Downloads (Pure)


K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study.

Brink M, de Goeij AF, Weijenberg MP, Roemen GM, Lentjes MH, Pachen MM, Smits KM, de Bruine AP, Goldbohm RA, van den Brandt PA.

Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Department of Epidemiology, Maastricht University, PO Box 616, The Netherlands. [email protected]

Activation of K-ras oncogene has been implicated in colorectal carcinogenesis, being mutated in 30-60% of the adenocarcinomas. In this study, 737 incident colorectal cancer (CRC) patients, originating from 120 852 men and women (55-69 years at baseline) participating in the Netherlands Cohort Study (NLCS), were studied in order to evaluate subgroups with respect to K-ras mutation status. Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8-29, was performed on archival colorectal adenocarcinoma samples of all patients using macrodissection, nested PCR and direct sequencing of purified fragments. The method of mutation detection was validated by the confirmation of reported K-ras status in CRC cell lines, a good correlation between fresh-frozen and routinely fixed, paraffin-embedded tissue, a detection limit of 5% mutated DNA and a good reproducibility. Various types of K-ras mutations were evaluated with respect to tumour sub-localization, Dukes' stage and tumour differentiation. In 37% (271/737) of the patients, the exon 1 fragment of K-ras gene was found to be mutated. The predominant mutations are G>A transitions and G>T transversions, and codons 12 and 13 are the most frequently affected codons. Patients with a rectal tumour were found to have the highest frequency of G>T transversions as compared with patients with a colon or rectosigmoid tumour. This difference appeared to be confined to women with a rectal tumour harbouring G>T transversions. No significant differences were observed for Dukes' stage with respect to types of K-ras mutation, which does not support direct involvement of the K-ras oncogene in adenocarcinoma progression. The equal distribution of K-ras mutations among cases with or without a family history of colorectal cancer argues against an important role for this mutation in familial colorectal cancer, and could imply that K-ras mutations are more probably involved in environmental mechanisms of colorectal carcinogenesis.

Original languageEnglish
Pages (from-to)703-710
Number of pages7
Issue number4
Publication statusPublished - 1 Jan 2003


Dive into the research topics of 'K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study'. Together they form a unique fingerprint.

Cite this